rxstat › Shortages › Desmopressin

Desmopressin (Ddavp, Octostim) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Oct 23, 2026

Also sold as: Ddavp, Octostim, Ddavp Rhinyle, Bipazen

Desmopressin has no current shortage reported in Canada. It has been in shortage before; the history is below.

A hormone medication used to treat diabetes insipidus and bedwetting, and to reduce excessive urination.

Products affected
0 / 13
Reports on file
36

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
DESMOPRESSIN SPRAY
10MCG · SPRAY (METERED-DOSE) · AA PHARMA INC
DIN 02242465 · ended Oct 22, 2026 · Disruption of the manufacture of the drug.
Resolved
DESMOPRESSIN SPRAY
10MCG · SPRAY (METERED-DOSE) · AA PHARMA INC
DIN 02242465 · ended Oct 22, 2026 · Disruption of the manufacture of the drug.
Resolved
BIPAZEN
4MCG · SOLUTION · KVR PHARMACEUTICALS INC.
DIN 02513579 · ended Jun 4, 2026 · Disruption of the manufacture of the drug.
Resolved
DESMOPRESSIN SPRAY
10MCG · SPRAY, METERED DOSE · AA PHARMA INC
DIN 02242465 · ended Mar 16, 2026 · Disruption of the manufacture of the drug.
Resolved
DESMOPRESSIN SPRAY
10MCG · SPRAY, METERED DOSE · AA PHARMA INC
DIN 02242465 · ended Mar 13, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-DESMOPRESSIN
0.1MG · TABLET · APOTEX INC
DIN 02284030 · ended Mar 12, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-DESMOPRESSIN
0.2MG · TABLET · APOTEX INC
DIN 02284049 · ended Jan 30, 2025 · Disruption of the manufacture of the drug.
Resolved
DESMOPRESSIN SPRAY
10MCG · SPRAY, METERED DOSE · AA PHARMA INC
DIN 02242465 · ended Jan 21, 2025 · Disruption of the manufacture of the drug.
Resolved
BIPAZEN
4MCG · SOLUTION · KVR PHARMACEUTICALS INC.
DIN 02513579 · ended Dec 30, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-DESMOPRESSIN
0.2MG · TABLET · APOTEX INC
DIN 02284049 · ended Oct 31, 2024 · Disruption of the manufacture of the drug.
Resolved
BIPAZEN
4MCG · SOLUTION · KVR PHARMACEUTICALS INC.
DIN 02513579 · ended Jun 20, 2023 · Disruption of the manufacture of the drug.
Resolved
DDAVP INJ 4MCG/ML
4MCG · LIQUID · FERRING INC
DIN 00873993 · ended May 12, 2023 · Product is on allocation

Showing 12 of 36 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Desmopressin. Health Canada has 36 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Desmopressin is classified under “POSTERIOR PITUITARY LOBE HORMONES” (ATC H01BA).

Recent changes

Common questions

What is Desmopressin used for?

A hormone medication used to treat diabetes insipidus and bedwetting, and to reduce excessive urination.

When will Desmopressin be back in stock in Canada?

Desmopressin has no active shortage; supply is normal per Health Canada reports.

Why is Desmopressin in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (posterior pituitary lobe hormones)

Carbetocin (Duratocin) No current shortage Desmopressin (Nocdurna) Discontinued 0 of 3 reported products affected Oxytocin No current shortage Vasopressin (Pressyn Ar) No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.